ClinicalTrials.Veeva

Menu

Triceps Surae Ultrasonographic Characteristics in Hemiparetic Stroke Survivors (TriUS)

A

Alessio Baricich

Status

Unknown

Conditions

Stroke
Spastic Foot

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This study aims to evaluate, in hemiparetic patients, changes in muscle ultrasound structure about the focal treatment of spasticity with botulinum toxin type A. For this purpose, the analysis of the mean echo intensity will be carried out on ultrasound acquisitions, identifying the possible correlations between the muscle echogenicity, the variations in the pennation angle, and the length of the fascicles.

For image processing operations, ImageJ software was applied.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • unilateral ischaemic or haemorrhagic stroke (documented with clinical examination and neuroradiological findings)
  • presence of spasticity at lower limb muscles, at least grade 1+ in the modified Ashworth Scale 3.
  • age ≥ 18 years

Exclusion criteria

  • inability to walk before stroke
  • presence of severe cognitive impairment
  • presence of other musculoskeletal, neurological or cardiopulmonary impairment which can interfere with clinical findings
  • presence of skin lesions that can contraindicate BoNT-A treatment
  • previous surgical myotendinous elongation

Trial contacts and locations

1

Loading...

Central trial contact

Alessio Baricich, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems